# FDA Inspection 823594 - Anshi Pharmaceutical (Zhongshan) Inc. - October 31, 2012

Source: https://www.keypedia.com/records/fda_inspections/anshi-pharmaceutical-zhongshan-inc/5ba36e06-8bcf-46e9-aef1-8c70336d0c9c
Source feed: FDA_Inspections

> FDA Inspection 823594 for Anshi Pharmaceutical (Zhongshan) Inc. on October 31, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 823594
- Company Name: Anshi Pharmaceutical (Zhongshan) Inc.
- Inspection Date: 2012-10-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1031944 - 2017-10-27](https://www.keypedia.com/records/fda_inspections/anshi-pharmaceutical-zhongshan-inc/3bc27a1f-511b-4bbd-8a31-de9c950fc7c7)
- [FDA Inspection 920920 - 2015-03-20](https://www.keypedia.com/records/fda_inspections/anshi-pharmaceutical-zhongshan-inc/36acbd2a-e801-40e0-a7ae-e1b8a2dda1b9)

Company: https://www.keypedia.com/companies/anshi-pharmaceutical-zhongshan-inc/233f6e41-0b8b-469b-8394-d9e9f3486774

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c